The German Indian Innovation Corridor (GIIC) in Berlin brought together leaders, innovators, and entrepreneurs from India and Germany to explore how collaboration can accelerate global innovation. The event highlighted how combining India’s scalability and creativity with Germany’s precision and execution can unlock transformative potential across industries.
Beyond panels and presentations, GIIC fostered a genuine community of innovators united by a shared mission to accelerate meaningful change, build resilient partnerships, and translate ideas into sustainable solutions that benefit society at large.
![]()
From Health Innovation to Equity in AI
Our CEO and CO-Founder Dr. Manasi Aichmueller-Ratnaparkhe joined an expert panel alongside Ruth R. Shah and Dr. med. Lara Maier, under the expert moderation of Dr. Jubin Shah. The session explored a broad spectrum of topics at the intersection of health and technology from holistic health and digital innovation ecosystems to AI-driven healthcare solutions and the growing role of responsible innovation in medicine.
A key theme of the discussion was health equity in AI, ensuring that technological advancements serve all populations, not just a privileged subset. The conversation reinforced a principle central to our mission and its Remaining84 initiative: that innovation in healthcare must begin with diverse, representative data and a patient-centered perspective. Only by embedding these values can AI in medicine become truly impactful and globally relevant.
![]()
A Shared Vision for Impact
The event offered an exceptional platform to connect with partners, investors, and innovators committed to driving responsible health innovation. It also underscored the importance of cross-cultural collaboration in tackling shared global challenges from improving access to quality healthcare to building fair and explainable AI systems.
We are proud to contribute to these dialogues, combining data diversity, AI excellence, and international collaboration to turn complex data into actionable diagnostics. From partnerships to practice, PAICON continues to build the bridge between innovation and real-world impact.